2-Pyrrolidone

2-Pyrrolidone

SCHEMBL3477689

O=C1CCCN1.[PoH2]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Pyrrolidone SCHEMBL4299593 0.97
2-Pyrrolidone SCHEMBL9304498 0.97 OR51E2 (1.00)
2-Pyrrolidone SCHEMBL2389 0.97
2-Pyrrolidone SCHEMBL27827832 0.97
2-Pyrrolidone SCHEMBL2167448 0.97 OR51E2 (1.00)
2-Pyrrolidone SCHEMBL5274639 0.94
2-Pyrrolidone SCHEMBL2518866 0.94
2-Pyrrolidone SCHEMBL511486 0.94
2-Pyrrolidone SCHEMBL11328078 0.94
2-Pyrrolidone SCHEMBL21858973 0.94

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1345611-B1 AN ANTIBIOTIC/ANALGESIC FORMULATION AND A METHOD OF MAKING THIS FORMULATION TEVA ANIMAL HEALTH INC (US) 2010-12-29 EP disclosed
US-20030224452-A1 Preparing immunoglobulin for use as tool in immunoassay for determining pregnancy in ruminants; animal husbandry; in vito fertilization; veterinary medicine ASPENBIO PHARMA, INC. 2003-12-04 US disclosed
US-5164454-A Impact strength TOAGOSEI CHEMICAL INDUSTRY CO., LTD. (JP) 1992-11-17 US disclosed